NOT FOR REPRINT
How to Plan for the Obesity Drug Revolution
By
Allison Bell
Analysis February 27, 2024 at 01:37 PM
Share & Print
What You Need To Know
- Life insurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.
- Fewer obesity-related health complications could mean many clients will have different long-term financial planning needs.
- The drugs still come with high costs, unpleasant side effects, and the possibility that they will work better for some people than others in the long term.
NOT FOR REPRINT
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
Immediate Answers to Critical Tax Questions At Your Fingertips
Keep up with the latest tax rules and regulations with weekly, exclusive updates by our Tax Facts experts.
Get More Information